‘Pharma Bro’ Martin Shkreli welcomes newborn son to the world with this bizarre name Martin Shkreli, the disgraced ex-pharmaceutical executive better known as "Pharma Bro," has become a father.© ...
The U.S. Supreme Court Nov. 18 denied to hear an appeal from disgraced pharmaceutical executive Martin Shkreli, according to CNBC. Mr. Shkreli will have to serve the remainder of his seven-year ...
Shares of Capricor Therapeutics (CAPR) slumped 17% on Monday morning after former biotech executive and businessman Martin ...
Disgraced pharmaceutical executive Martin Shkreli has been ordered to forfeit his copies of the Wu-Tang Clan’s rare album, “Once Upon a Time in Shaolin.” The request is part of a preliminary ...
Imagine needing a medication that costs less than a fast-food meal—only to wake up the next day and find it's suddenly priced like a luxury car payment…per single pill. That's exactly what happened in ...
A Brooklyn judge ordered pharmaceuticals investor Martin Shkreli to hand over all copies he might have made of the very rare Wu-Tang Clan album “Once Upon a Time in Shaolin” by Friday. The 41-year-old ...
NEW YORK (AP) – The smirk wiped off his face, a crying Martin Shkreli was sentenced to seven years in prison for securities fraud Friday in a hard fall for the pharmaceutical-industry bad boy vilified ...
In this Aug. 3, 2017, file photo, Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, arrives at federal court in Brooklyn, New York. automation Martin Shkreli's lifetime ban ...
Notorious "Pharma bro" fraudster Martin Shkreli was released from a federal prison in Pennsylvania on Wednesday and into a U.S. Bureau of Prisons halfway house at an undisclosed location in New York ...
WASHINGTON (AP) — The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed "Pharma Bro" afterjacking up the price of a lifesaving drug. Shkreli appealed an order to ...
The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug. Shkreli appealed an order to return $64.6 million ...